跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,549 条关于
“MK-8690”
全部
2,549
临床试验
1,915
药物
532
机构
0
资讯
102
10个月前
Merck Assumes Full Control of MK-8690 Anti-CD30 Ligand Antibody for Inflammatory Bowel Disease
去年
Lantheus' Alzheimer's Radiodiagnostic MK-6240 Achieves Pivotal Study Success, NDA Filing Planned
5个月前
Merck Discontinues In-House TROP2 ADC MK-6837 After Revealing Dual Development Strategy
去年
Clesrovimab Shows Promise in Preventing RSV Infections in Infants
9个月前
Merck Receives FDA Fast Track Designation for Novel Alzheimer's Tau-Targeting Antibody MK-2214
2年前
Merck Launches Phase 3 Trial of MK-1084 Plus Pembrolizumab for KRAS G12C-Mutated NSCLC
3年前
Merck Launches First Phase 3 Program for Oral PCSK9 Inhibitor MK-0616 to Treat High Cholesterol
去年
Phase 3 Trial of Opevesostat vs. NHA Switch in Metastatic Castration-Resistant Prostate Cancer
5个月前
Merck Launches First Pivotal Trial of CD19 T-Cell Engager MK-1045 Against Blincyto in B-ALL
5个月前
Merck Initiates Pivotal Phase 2b/3 Trial for Novel Bispecific Antibody MK-8748 in Wet Age-Related Macular Degeneration
第 1 页,共 11 页
上一页
下一页